Trial Condition(s):

Diabetes Mellitus, Type 1

Effect of 3 months of acarbose (BAY G 5421) therapy on the glycosylated haemoglobin content in the blood of children treated with insulin

Bayer Identifier:

Trial_234

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

October1977

September1980

Phase

N/A

Could I receive a placebo?

Products

Acarbose (Precose/Glucobay, BAYG5421)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Diabetes Mellitus, Type 1

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

11 Years

18 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information